Medicine chamber spacer
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
20-07-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
GlaxoSmithKline Australia Pty Ltd
Class:
Class IIb
Manufactured by:
GlaxoSmithKline Trading Services Limited 12 Riverwalk Citywest Business Campus, Dublin 24, D24 YK11 Ireland
Therapeutic area:
38018 - Medicine chamber spacer
Therapeutic indications:
The Volumatic Spacer Device is a breath activated holding device designed to enable the use of the pressurised metered dose inhaler by a patient. A chamber for use with Seretide, Ventolin and Flixotide metered dose aerosol inhalers, designed to hold the spray before it is breathed in.
Authorization status:
A
Authorization date:
2022-10-25
